If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPF.L Regulatory News (APF)

  • There is currently no data for APF

Rule 8.3- Hidefield Gold plc

21 Sep 2009 11:21

RNS Number : 3822Z
Anglo Pacific Group PLC
21 September 2009
ย 

ย  FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MOREย 

(Rule 8.3 ofย theย Takeoverย Code)

1. KEY INFORMATION

Name of person dealingย ย (Note 1)

Anglo Pacific Group plc

ย 

Company dealt in

Hidefield Gold plc

ย 

Class of relevant security to which the dealings being disclosed relateย (Note 2)

ย 

Ordinary Shares

Date of dealing

ย 

18ย September 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interestsย and short positionsย (following dealing) in the class of relevant security dealt inย (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesย 

61,376,504 14.96%

(2) Derivativesย (other than options)

0 0%

(3)ย Optionsย and agreements to purchase/sell

0 0%

Total

61,376,504 14.96%

(b) Interestsย and short positionsย in relevant securities of the company, other than theย classย dealt inย (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesย 

(2) Derivativesย (other than options)

(3)ย Optionsย and agreements to purchase/sell

Total

(c) Rights to subscribeย (Note 3)

Class of relevant security:

Details

3. DEALINGSย (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unitย (Note 5)

Sale

1,100,000

ยฃ0.0225

(b) Derivatives transactions (other than options)

Product name,ย 

e.g. CFD

Long/shortย (Noteย 6)

Number of securitiesย (Note 7)

Price per unitย (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.ย callย option

Writing, selling, purchasing, varying etc.

Number of securitiesย to which the option relatesย (Note 7)

Exercise

priceย 

Type,ย e.g. American, European etc.

Expiryย 

date

Option money

paid/receivedย per unitย (Note 5)ย 

(ii) Exercising

Product name,ย e.g.ย call option

Number of securitiesย 

Exercise priceย per unitย (Note 5)

(d) Other dealings (including new securities)ย (Note 4)

Nature of transactionย (Note 8)

Details

Priceย per unitย (if applicable)ย (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form orย relating to the voting rights orย future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?ย (Note 9) NO

Date of disclosure

21ย September 2009

ย 

Contact name

Matthew Tack

ย 

Telephone number

020 7318 6360

ย 

If a connected EFM, name of offeree/offeror with which connected

N/A

ย 

If a connected EFM,ย state natureย of connectionย (Noteย 10)

N/A

ย 

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website atย www.thetakeoverpanel.org.uk

ย 

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
RETZGGZLGMGGLZM
Date   Source Headline
3rd Dec 20152:58 pmRNSDirector's Share Dealings
2nd Dec 20154:04 pmRNSDirectors' Share Dealings
30th Nov 20151:47 pmRNSHolding(s) in Company
30th Nov 20151:45 pmRNSDirector's Share Dealings
27th Nov 20157:00 amRNSDirectors' & PDMR's Share Dealings
26th Nov 20157:02 amRNSQ3 2015 Trading Update
12th Nov 20153:20 pmRNSNotice of Q3 2015 Trading Update
5th Nov 20157:00 amRNSSalamanca Project Pre-Feasibility Study
26th Oct 20157:00 amRNSResponse to share price movement
16th Oct 20158:33 amRNSTransfer of Listing
16th Oct 20157:00 amRNSKestrel Royalty Update
15th Oct 20157:00 amRNSNarrabri Royalty Update
2nd Oct 201511:19 amRNSCompany Share Option Plan & Notification of PDMR
17th Sep 201512:11 pmRNSResults of General Meeting
28th Aug 20152:00 pmRNSDirector/PDMR Shareholding
26th Aug 20151:56 pmRNSPublication of Circular
26th Aug 20157:01 amRNSProposed Transfer of Listing Category
26th Aug 20157:00 amRNSHalf Yearly Report
13th Aug 20157:00 amRNSNarrabri production guidance FY2016
29th Jul 20153:02 pmRNSNotice of Interim Results
17th Jul 20157:00 amRNSRoyalty Update: Narrabri
16th Jul 20157:00 amRNSRoyalty Update: Kestrel
29th Jun 20152:00 pmRNSDirector's Share Dealings
18th Jun 20152:00 pmRNSDirector's Share Dealings
15th Jun 20153:35 pmRNSDirector's Share Dealings
10th Jun 20152:06 pmRNSDirector's Share Dealings
1st Jun 201510:00 amRNSDirector's Share Dealings
26th May 20154:00 pmRNSResignation of Executive Director
15th May 20158:00 amRNSDirector/PDMR Shareholding
14th May 20157:00 amRNSInterim Management Statement
6th May 20154:30 pmRNSNew corporate website
1st May 201510:00 amRNSBoard Changes
30th Apr 20152:10 pmRNSResult of AGM
23rd Apr 20157:00 amRNSKestrel update and 2016 guidance
21st Apr 20158:00 amRNSNarrabri Updated Guidance
31st Mar 20157:00 amRNSTotal Voting Rights
30th Mar 201510:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Mar 20158:00 amRNSNotice of AGM
26th Mar 20158:00 amRNSDirector/PDMR Shareholding
25th Mar 20157:00 amRNSResults for the year ended December 31, 2014
16th Mar 20153:55 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
11th Mar 20157:00 amRNSCompletion of Narrabri Royalty Acquisition
9th Mar 20157:00 amRNSNotice of Results
6th Mar 20157:00 amRNSCompletion of Narrabri Royalty Acquisition
5th Mar 201510:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
2nd Mar 20157:00 amRNSTotal Voting Rights
26th Feb 20152:05 pmRNSResults of General Meeting
26th Feb 20157:01 amRNSResults of Open Offer
17th Feb 201510:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Feb 201510:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.